Lucid Diagnostics Stock Forecast, Price & News

Lucid Diagnostics (NASDAQ:LUCD) Frequently Asked Questions

Is Lucid Diagnostics a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lucid Diagnostics in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Lucid Diagnostics stock.
View analyst ratings for Lucid Diagnostics or view top-rated stocks.

What price target have analysts set for LUCD?

4 brokerages have issued 1 year price objectives for Lucid Diagnostics' stock. Their forecasts range from $14.00 to $21.00. On average, they anticipate Lucid Diagnostics' share price to reach $17.50 in the next twelve months. This suggests a possible upside of 117.1% from the stock's current price.
View analysts' price targets for Lucid Diagnostics or view top-rated stocks among Wall Street analysts.

Who are some of Lucid Diagnostics' key competitors?

Some companies that are related to Lucid Diagnostics include OrthoPediatrics (KIDS), Alphatec (ATEC), LeMaitre Vascular (LMAT), AngioDynamics (ANGO), Bioventus (BVS), Sight Sciences (SGHT), Treace Medical Concepts (TMCI), Intersect ENT (XENT), Cardiovascular Systems (CSII), Longview Acquisition Corp. II (LGV), MiMedx Group (MDXG), OraSure Technologies (OSUR), CryoLife (CRY), SI-BONE (SIBN) and Pulse Biosciences (PLSE).
View all of LUCD's competitors.

When did Lucid Diagnostics IPO?

(LUCD) raised $75 million in an IPO on Thursday, October 14th 2021. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share.

What is Lucid Diagnostics' stock symbol?

Lucid Diagnostics trades on the NASDAQ under the ticker symbol "LUCD."

When did Lucid Diagnostics' quiet period expire?

Lucid Diagnostics' quiet period expired on Tuesday, November 23rd. Lucid Diagnostics had issued 5,000,000 shares in its public offering on October 14th. The total size of the offering was $70,000,000 based on an initial share price of $14.00. During Lucid Diagnostics' quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Lucid Diagnostics?

Shares of LUCD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lucid Diagnostics' stock price today?

One share of LUCD stock can currently be purchased for approximately $8.06.

How much money does Lucid Diagnostics make?

Lucid Diagnostics has a market capitalization of $296.69 million.

How many employees does Lucid Diagnostics have?

Lucid Diagnostics employs 2,021 workers across the globe.

What is Lucid Diagnostics' official website?

The official website for Lucid Diagnostics is www.luciddx.com.

How can I contact Lucid Diagnostics?

The company can be reached via phone at 212-949-4319 or via email at [email protected].